| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |